1887

Abstract

An effective vaccine against serogroup B is required. Outer-membrane protein vaccines have been developed, which may provide protection against common circulating serotypes and serosubtypes in some countries. However, limited genosubtyping data are available because most laboratories use mAbs directed against a limited number of specific serotypes and serosubtypes and laboratories do not genosubtype directly from body fluids due to the lack of a sensitive PCR method. A nested PCR was therefore developed that enables the amplification of the gene directly from clinical samples and has the required sensitivity for nucleotide sequencing of the three main variable regions, VR1, VR2 and VR3. Data were compared with those from culture-based nucleotide sequencing, and the use of this method increased the availability of genosubtype information by 45 %, thereby indicating the impact that this methodology has on the data provided and the implications for vaccine design.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05032-0
2003-01-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/1/51.html?itemId=/content/journal/jmm/10.1099/jmm.0.05032-0&mimeType=html&fmt=ahah

References

  1. Al'Aldeen A. A, Cartwright K. A. 1996; Neisseria meningitidis : vaccines and vaccine candidates. J Infect 33:153–157 [CrossRef]
    [Google Scholar]
  2. Borrow R, Claus H, Guiver M, Smart L, Jones D. M, Kaczmarski E. B, Frosch M, Fox A. J. 1997; Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase ( sia D) PCR ELISA. Epidemiol Infect 118:111–117 [CrossRef]
    [Google Scholar]
  3. Borrow R, Claus H, Chaudhry U, Guiver M, Kaczmarski E. B, Frosch M, Fox A. J. 1998a; sia D PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett 159:209–214 [CrossRef]
    [Google Scholar]
  4. Borrow R, Guiver M, Sadler F, Kaczmarski E. B, Fox A. J. 1998b; False positive diagnosis of meningococcal infection by the IS1106 PCR ELISA. FEMS Microbiol Lett 162:215–218 [CrossRef]
    [Google Scholar]
  5. Clarke S. C, Diggle M. A, Edwards G. F. 2001a; Automated non-culture-based sequence typing of meningococci from body fluids. Br J Biomed Sci 58:230–234
    [Google Scholar]
  6. Clarke S. C, Diggle M. A, Edwards G. F. 2001b; Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis . J Clin Microbiol 39:3066–3071 [CrossRef]
    [Google Scholar]
  7. Clarke S. C, Diggle M. A, Reid J. A, Thom L, Edwards G. F. 2001c; Introduction of an automated service for the laboratory confirmation of meningococcal disease in Scotland. J Clin Pathol 54:556–557 [CrossRef]
    [Google Scholar]
  8. Clarke S. C, Reid J, Thom L, Denham B. C, Edwards G. F. 2002; Laboratory confirmation of meningococcal disease in Scotland, 1993–9. J Clin Pathol 55:32–36 [CrossRef]
    [Google Scholar]
  9. Claus H, Maiden M. C. J, Maag R, Frosch M, Vogel U. 2002; Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813–1819
    [Google Scholar]
  10. Connolly M, Noah N. 1999; Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6. European Meningitis Surveillance Group. Epidemiol Infect 122:41–49 [CrossRef]
    [Google Scholar]
  11. Corless C. E, Guiver M, Borrow R, Edwards-Jones V, Fox A. J, Kaczmarski E. B. 2001; Simultaneous detection of Neisseria meningitidis , Haemophilus influenzae , and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553–1558 [CrossRef]
    [Google Scholar]
  12. Diggle M. A, Edwards G. F. S, Clarke S. C. 2001a; Automation of fluorescence-based PCR for confirmation of meningococcal disease. J Clin Microbiol 39:4518–4519 [CrossRef]
    [Google Scholar]
  13. Diggle M. A, Edwards G. F. S, Clarke S. C. 2001b; Developments in the diagnosis of meningococcal disease and the characterization of Neisseria meningitidis . Rev Med Microbiol 12:211–217 [CrossRef]
    [Google Scholar]
  14. Eldridge J, Sutcliffe E. M, Abbott J. D, Jones D. M. 1978; Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by coagglutination. Med Lab Sci 35:63–66
    [Google Scholar]
  15. Feavers I. M, Fox A. J, Gray S, Jones D. M, Maiden M. C. 1996; Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 3:444–450
    [Google Scholar]
  16. Feavers I. M, Gray S. J, Urwin R, Russell J. E, Bygraves J. A, Kaczmarski E. B, Maiden M. C. 1999; Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J Clin Microbiol 37:3883–3887
    [Google Scholar]
  17. Finne J, Bitter-Suermann D, Goridis C, Finne U. 1987; An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138:4402–4407
    [Google Scholar]
  18. Frasch C. E, Zollinger W. D, Poolman J. T. 1985; Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7:504–510 [CrossRef]
    [Google Scholar]
  19. Guiver M, Borrow R, Marsh J, Gray S. J, Kaczmarski E. B, Howells D, Boseley P, Fox A. J. 2000; Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 28:173–179 [CrossRef]
    [Google Scholar]
  20. Hayrinen J, Jennings H, Raff H. V, Rougon G, Hanai N, Gerardy-Schahn R, Finne J. 1995; Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J Infect Dis 171:1481–1490 [CrossRef]
    [Google Scholar]
  21. Jelfs J, Munro R, Wedege E, Caugant D. A. 2000; Sequence variation in the por A gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol 7:390–395
    [Google Scholar]
  22. Maiden M. C, Suker J, McKenna A. J, Bygraves J. A, Feavers I. M. 1991; Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis . Mol Microbiol 5:727–736 [CrossRef]
    [Google Scholar]
  23. Maiden M. C, Bygraves J. A, McCarvil J, Feavers I. M. 1992; Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol 30:2835–2841
    [Google Scholar]
  24. Maiden M. C, Bygraves J. A, Feil E. 10 other authors 1998; Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140–3145 [CrossRef]
    [Google Scholar]
  25. McGuinness B. T, Lambden P. R, Heckels J. E. 1993; Class 1 outer membrane protein of Neisseria meningitidis : epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 7:505–514 [CrossRef]
    [Google Scholar]
  26. Molling P, Unemo M, Backman A, Olcen P. 2000; Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS 108:509–516 [CrossRef]
    [Google Scholar]
  27. Molling P, Backman A, Olcen P, Fredlund H. 2001; Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J Clin Microbiol 39:2695–2699 [CrossRef]
    [Google Scholar]
  28. Newcombe J, Cartwright K, Palmer W. H, McFadden J. 1996; PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 34:1637–1640
    [Google Scholar]
  29. Ni H, Knight A. I, Cartwright K, Palmer W. H, McFadden J. 1992; Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 340:1432–1434 [CrossRef]
    [Google Scholar]
  30. Olcen P, Danielsson D, Kjellander J. 1975; The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta Pathol Microbiol Scand B 83:387–396
    [Google Scholar]
  31. Rappuoli R. 2001; Conjugates and reverse vaccinology to eliminate bacterial meningitis. Vaccine 19:2319–2322 [CrossRef]
    [Google Scholar]
  32. Rosenstein N. E, Fischer M, Tappero J. W. 2001; Meningococcal vaccines. Infect Dis Clin North Am 15:155–169 [CrossRef]
    [Google Scholar]
  33. Saunders N. B, Zollinger W. D, Rao V. B. 1993; A rapid and sensitive PCR strategy employed for amplification and sequencing of por A from a single colony-forming unit of Neisseria meningitidis . Gene 137:153–162 [CrossRef]
    [Google Scholar]
  34. Smith N. H, Maynard Smith J, Spratt B. G. 1995; Sequence evolution of the por B gene of Neisseria gonorrhoeae and Neisseria meningitidis : evidence of positive Darwinian selection. Mol Biol Evol 12:363–370
    [Google Scholar]
  35. Suker J, Feavers I. M, Achtman M, Morelli G, Wang J. F, Maiden M. C. 1994; The por A gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 12:253–265 [CrossRef]
    [Google Scholar]
  36. Urwin R, Kaczmarski E. B, Guiver M, Fox A. J, Maiden M. C. 1998a; Amplification of the meningococcal por B gene for non-culture serotype characterization. Epidemiol Infect 120:257–262 [CrossRef]
    [Google Scholar]
  37. Urwin R, Fox A. J, Musilek M, Kriz P, Maiden M. C. 1998b; Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis . J Clin Microbiol 36:3680–3682
    [Google Scholar]
  38. Urwin R, Feavers I. M, Jones D. M, Maiden M. C, Fox A. J. 1998c; Molecular variation of meningococcal serotype 4 antigen genes. Epidemiol Infect 121:95–101 [CrossRef]
    [Google Scholar]
  39. van der Ley P, Heckels J. E, Virji M, Hoogerhout P, Poolman J. T. 1991; Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 59:2963–2971
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05032-0
Loading
/content/journal/jmm/10.1099/jmm.0.05032-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error